Lingfang Ye

No ORCID on file · 4 papers in corpus · active 2021-2024

Study types

  • article 3
  • preprint 1

Condition tags

  • endometriosis 2
  • adenomyosis 2
  • dysmenorrhea 1
  • mesh:D004715 1
  • mesh:D004412 1
article 2024
Disrupted Tuzzerella abundance and impaired l-glutamine levels induce Treg accumulation in ovarian endometriosis: a comprehensive multi-omics analysis
Metabolomics : Official journal of the Metabolomic Society ·doi:10.1007/s11306-023-02072-0

INTRODUCTION: The microbial community plays a crucial role in the pathological microenvironment. However, the structure of the microbial community within endometriotic lesions and its impact on the microenvironment is still limited. METHODS…

preprint 2023
Disrupted Tuzzerella Abundance and Impaired L-Glutamine Levels Induce Treg Accumulation in Ovarian Endometriosis: A Comprehensive Multi-Omics Analysis
·doi:10.2139/ssrn.4555258
article 2023
Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms
JAMA network open ·doi:10.1001/jamanetworkopen.2023.17860

Importance: Adenomyosis is a common chronic gynecological disorder, and its treatment is an unmet need. New therapies need to be developed. Mifepristone is being tested for adenomyosis treatment. Objective: To determine whether mifepristone…

article 2021
Mifepristone Treats Symptomatic Adenomyosis: A Multicentre, Randomized, Double-Blind and Placebo-Controlled Trial
·doi:10.2139/ssrn.3897694